Home LiteratureArticle Details
PMID: 20375314 Published · ppublish English Journal Article

Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment.

Blood ·Vol. 115 ·No. 24 ·2010-06-17 ·Pages 5053-6

Clear AJ, Lee AM, Calaminici M, Ramsay AG, Morris KJ, Hallam S, Kelly G, Macdougall F, Lister TA, Gribben JG

Abstract

Follicular lymphoma has considerable clinical heterogeneity, and there is a need for easily quantifiable prognostic biomarkers. Microvessel density has been shown to be a useful prognostic factor based on numerical assessment of vessel numbers within histologic sections in some studies, but assessment of tumor neovascularization through angiogenic sprouting may be more relevant. We therefore examined the smallest vessels, single-staining structures measuring less than 30 microm(2) in area, seen within histologic sections, and confirmed that they were neovascular angiogenic sprouts using extended focal imaging. Tissue microarrays composing diagnostic biopsies from patients at the extremes of survival of follicular lymphoma were analyzed with respect to numbers of these sprouts. This analysis revealed higher angiogenic activity in the poor prognostic group and demonstrated an association between increased sprouting and elevated numbers of infiltrating CD163(+) macrophages within the immediate microenvironment surrounding the neovascular sprout.

MeSH Terms
Antigens, CD/metabolism Antigens, Differentiation, Myelomonocytic/metabolism Biomarkers, Tumor/metabolism Biopsy Humans Lymphoma, Follicular/pathology Macrophages/metabolism,pathology Neovascularization, Pathologic/pathology Platelet Endothelial Cell Adhesion Molecule-1/metabolism Prognosis Receptors, Cell Surface/metabolism
Chemicals
Antigens, CD Antigens, Differentiation, Myelomonocytic Biomarkers, Tumor CD163 antigen Platelet Endothelial Cell Adhesion Molecule-1 Receptors, Cell Surface
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Clear Andrew J
Centre for Medical Oncology, Queen Mary University of London, Barts, United Kingdom.
Lee Abigail M
Calaminici Maria
Ramsay Alan G
Morris Kelly J
Hallam Simon
Kelly Gavin
Macdougall Finlay
Lister T Andrew
Gribben John G
References (28)
28 references, click to expand
  1. High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.
    J Clin Oncol. 2008 Jan 20;26(3):440-6 PMID: 18086798
  2. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy.
    Eur J Cancer. 2006 Apr;42(6):717-27 PMID: 16520032
  3. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.
    J Clin Oncol. 2009 Sep 20;27(27):4555-62 PMID: 19652063
  4. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    J Clin Oncol. 2007 Jun 10;25(17):2426-33 PMID: 17485708
  5. Obligatory participation of macrophages in an angiopoietin 2-mediated cell death switch.
    Development. 2007 Dec;134(24):4449-58 PMID: 18039971
  6. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
    Cancer Res. 1996 Oct 15;56(20):4625-9 PMID: 8840975
  7. Increased vascularization predicts favorable outcome in follicular lymphoma.
    Clin Cancer Res. 2005 Jan 1;11(1):154-61 PMID: 15671540
  8. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
    J Clin Oncol. 2007 Aug 1;25(22):3330-6 PMID: 17664481
  9. Molecular characterization of lymphatic endothelial cells.
    Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16069-74 PMID: 12446836
  10. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors.
    J Clin Oncol. 2005 Sep 10;23(26):6358-63 PMID: 16155020
  11. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).
    Blood. 2005 Sep 15;106(6):2169-74 PMID: 15933054
  12. Histological transformation of non-Hodgkin's lymphoma: a prospective study.
    Cancer. 1979 Aug;44(2):645-51 PMID: 383259
  13. Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas.
    Br J Cancer. 1999 Feb;79(5-6):965-70 PMID: 10070898
  14. Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors.
    J Immunol. 2010 Jan 15;184(2):702-12 PMID: 20018620
  15. Double immunofluorescence labelling of routinely processed paraffin sections.
    J Pathol. 2000 Aug;191(4):452-61 PMID: 10918222
  16. Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction.
    J Invest Dermatol. 2009 Apr;129(4):1016-25 PMID: 18843292
  17. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.
    N Engl J Med. 2004 Nov 18;351(21):2159-69 PMID: 15548776
  18. Angiogenesis in renal cell carcinoma: the role of tumor-associated macrophages.
    Int J Urol. 2009 Oct;16(10):801-7 PMID: 19811548
  19. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center.
    J Clin Oncol. 1995 Jan;13(1):140-7 PMID: 7799014
  20. Follicular lymphoma international prognostic index.
    Blood. 2004 Sep 1;104(5):1258-65 PMID: 15126323
  21. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli.
    J Leukoc Biol. 2000 Jan;67(1):97-103 PMID: 10648003
  22. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.
    J Clin Oncol. 2007 Feb 1;25(4):390-8 PMID: 17200149
  23. Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.
    Haematologica. 2009 Jan;94(1):70-7 PMID: 19059937
  24. Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma.
    Br J Cancer. 2003 Feb 24;88(4):553-9 PMID: 12592369
  25. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature.
    Nature. 2005 Sep 15;437(7057):417-21 PMID: 16163358
  26. Tumor-associated macrophage correlated with angiogenesis and progression of mucoepidermoid carcinoma of salivary glands.
    Ann Surg Oncol. 2009 Mar;16(3):751-60 PMID: 19116756
  27. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast.
    Br J Cancer. 1999 Feb;79(5-6):991-5 PMID: 10070902
  28. Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome.
    J Clin Oncol. 2006 Nov 1;24(31):5052-9 PMID: 17033038
Article Info
Journal
Blood
Abbr.
Blood
ISSN
1528-0020
Published
2010-06-17
Epub
2010-00-07
Pages
5053-6
Language
English
Region
United States
NLM ID
7603509
PMCID
PMC2890144
Subset
IM
Grants
NCI NIH HHS · P01 CA095426 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com